Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Scottsdale Scientific, Inc. (STDS) -- Ignore unavailable to you. Want to Upgrade?

To: dannyboy who wrote (56)	4/12/1999 2:51:00 PM
From: Jim Bishop	Respond to of 105

Cool, here's the meat of it: Monday April 12, 11:58 am Eastern Time Company Press Release Investors Research Institute Inc. Announces Investment Opinion on Scottsdale Scientific Public Analysis & Review - PAR - Announces Scottsdale Scientific Will Be Covered Quarterly by Analyst Gerald F. LaJarafeaux, CFA NEW YORK--(BUSINESS WIRE)--April 12, 1999-- --(Investrend Research)-- Public Analysis & Review (PAR), administered by the non-profit Investors Research Institute, Inc. and distributed by Investrend Research, has announced that Gerald LaKarnafeaux, CFA, Ivins, UT, a professional analyst qualified in its unique continuing analyst program, will initiate coverage of Scottsdale Scientific (OTCBB:STDS - news) beginning immediately. During the past 30 years, Mr. LaKarnafeaux has held senior positions in international and regional investment banking firms as a securities analyst, portfolio manager and director of corporate finance. Mr. LaKarnafeaux is a principal of the consulting firm, Key Ratios, Inc., which assists early stage private and public companies in the areas of corporate valuation and capital formation. He has been an active member and officer of regional chapters of the Financial Analysts Society, the Corporate Finance Council and the American Society of Appraisers. The initial report is expected to be issued within a few weeks, and afterwards STDS will be reviewed on a quarterly basis following the issuance of each earnings report. Scottsdale Scientific, Inc. (OTCBB: STDS - news) is an innovative leader in nutraceutical research and product formulations. Since 1979, the Company has been noted for high quality, hypoallergenic nutritional supplements and supplies products to approximately 6,000 physicians and health are practitioners world-wide. Now in its 20th year in business, STDS has commenced an extensive expansion protocol which includes: Showcasing and marketing select products to the general public; Phase I of a pharmacy expansion program, targeting 40,000 independent and 29,000 chain pharmacies; the launch of an Internet marketing campaign; and world-wide retail distribution of its TOTAL NUTRIENT LINE.

To: dannyboy who wrote (56)	4/12/1999 4:15:00 PM
From: Jim Bishop	Read Replies (1) \| Respond to of 105

Last 10 trades: 15:24:50 2.468 1000 NASDAQ OTC BBS (domestic) at Ask 15:24:29 2.250 2000 NASDAQ OTC BBS (domestic) at Bid 15:24:15 2.250 1300 NASDAQ OTC BBS (domestic) at Bid 15:23:24 2.400 8500 NASDAQ OTC BBS (domestic) 15:18:06 2.380 800 NASDAQ OTC BBS (domestic) 15:18:03 2.375 1500 NASDAQ OTC BBS (domestic) at Bid 15:14:59 2.468 8500 NASDAQ OTC BBS (domestic) at Ask 15:14:54 2.468 7500 NASDAQ OTC BBS (domestic) at Ask 14:49:37 2.468 600 NASDAQ OTC BBS (domestic) at Ask 14:14:40 2.375 400 NASDAQ OTC BBS (domestic) at Bid